B2.jpg b2_ph.jpg
Team
  • Dayao ZHAO M.D., Ph.D.

    Chief Executive Officer

    AffaMed Therapeutics

  • Ji LI Ph.D.

    President, Chief Strategy Officer & Director

    AffaMed Therapeutics

  • Vijay P. Karwal M.Sc., CFA

    Chief Financial Officer

    AffaMed Therapeutics

  • Cen XU Ph.D.

    Chief Scientific Officer

    AffaMed Therapeutics

  • Minji Kim Ph.D., M.B.A.

    General Manager, AffaMed Digital

  • Rose YU M.D., MSc & EMBA

    Chief Regulatory Officer

    AffaMed Therapeutics

  • Yi HAN Ph.D.

    General Manager, AffaMed Technologies

    VP, Strategy and PPM, AffaMed Therapeutics

×

Mengjiao JIANG

Managing Director

Ms. Jiang has over 17 years of investment, merger and acquisition and investment banking experience. She is Managing Director of CBC Group, a healthcare-dedicated private equity firm, and has served as a Partner and a Managing Director since January 2014. Ms. Jiang currently also serves on the board of several private companies.

Ms. Jiang served as Director and COO at Far East Horizon’s Investments Group, a financial services organization, from March 2012 to December 2013. Prior to that, Ms. Jiang served at ARC China Inc. as Managing Director, as well as Associate Director at BDA, a cross border M&A firm, and UBS Investment Bank in New York.

Ms. Jiang received her bachelor’s degree in Economics with a Political Science double major from Wellesley College in Massachusetts in May 2003